Chinese SFDA Deputy Director Under Investigation For Corruption
This article was originally published in PharmAsia News
Executive Summary
BEIJING - A deputy director of China's State FDA is under investigation by the Communist Party's top anti-corruption commission, which could have broad ramifications for the drug agency's daily operations
You may also be interested in...
China FDA Launches Major Enforcement Campaign; Official Cautions Rainy Days Ahead
If a widening anti-bribery investigation, a new drug cost survey and looming pricing reform is not enough, China FDA just launched its first major campaign to root out violations in pharmaceutical manufacturing and distribution. Industry needs to get ready for rainy days, an official cautioned.
China FDA Launches Major Enforcement Campaign; Official Cautions Rainy Days Ahead
If a widening anti-bribery investigation, a new drug cost survey and looming pricing reform is not enough, China FDA just launched its first major campaign to root out violations in pharmaceutical manufacturing and distribution. Industry needs to get ready for rainy days, an official cautioned.
China FDA Launches Major Enforcement Campaign; Official Cautions Rainy Days Ahead
If a widening anti-bribery investigation, a new drug cost survey and looming pricing reform is not enough, China FDA just launched its first major campaign to root out violations in pharmaceutical manufacturing and distribution. Industry needs to get ready for rainy days, an official cautioned.